用于估计免疫治疗生物标志物的靶向基因组的数据驱动设计
Data-driven design of targeted gene panels for estimating immunotherapy biomarkers
摘要:
我们介绍了一种新的数据驱动的框架,用于设计靶向基因组,以估计癌症免疫治疗中的外显子组范围的生物标志物。我们的第一个目标是开发一个跨外显子组突变谱的生成模型,该模型允许基因和变异类型依赖的突变率。基于这个模型,我们提出了一个新的程序来估计生物标志物,如肿瘤突变负荷和肿瘤indel nurden。我们的方法允许从业者选择一个预定大小的靶基因面板,然后构建一个仅依赖于所选基因的估计量。或者,从业者可以应用我们的方法来基于现有的基因面板进行预测,或者将基因面板增加到给定的大小。我们使用来自三项非小细胞肺癌研究的数据以及来自其他六种癌症类型的数据证明了我们的提案的出色性能。
英文摘要:
We introduce a novel data-driven framework for the design of targeted gene panels for estimating exome-wide biomarkers in cancer immunotherapy. Our first goal is to develop a generative model for the profile of mutation across the exome, which allows for gene- and variant type-dependent mutation rates. Based on this model, we then propose a new procedure for estimating biomarkers such as tumour mutation burden and tumour indel nurden. Our approach allows the practitioner to select a targeted gene panel of a prespecified size, and then construct an estimator that only depends on the selected genes. Alternatively, the practitioner may apply our method to make predictions based on an existing gene panel, or to augment a gene panel to a given size. We demonstrate the excellent performance of our proposal using data from three non-small cell lung cancer studies, as well as data from six other cancer types.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。